The epidemiology, pathogenesis and histopathology of fatty liver disease

Levene A P & Goldin R D 
(2012) Histopathology 61, 141–152

[1]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[2]  A. Nanji,et al.  Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil , 1998, Hepatology.

[3]  P. Schauer,et al.  Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  C. Day.  Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[5]  H. Tilg,et al.  Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. , 2006, Gastroenterology.

[6]  N. Kaplowitz,et al.  ER stress: can the liver cope? , 2006, Journal of hepatology.

[7]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[8]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[9]  Defeng Wu,et al.  Alcohol, Oxidative Stress, and Free Radical Damage , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[10]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[11]  M. Bennett,et al.  Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.

[12]  G. Ioannou,et al.  Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population , 2009, Hepatology.

[13]  B. Grant,et al.  The critical dimension of ethnicity in liver cirrhosis mortality statistics. , 2001, Alcoholism, clinical and experimental research.

[14]  H. Bonkovsky,et al.  Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. , 2000, American journal of clinical pathology.

[15]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[16]  F. Marra,et al.  Adipokines and liver fibrosis. , 2005, European review for medical and pharmacological sciences.

[17]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[18]  G. Gores,et al.  O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF‐ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY , 2004, Journal of Pediatric Gastroenterology and Nutrition.

[19]  G. Gores,et al.  Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.

[20]  I. Leclercq,et al.  Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. , 2003, Journal of hepatology.

[21]  R. Fisher,et al.  Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  V. Fogliano,et al.  Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins , 2010, Hepatology.

[23]  G. Gores,et al.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.

[24]  J. Crespo,et al.  Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .

[25]  Kurt Zatloukal,et al.  Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. , 2008, Journal of Hepatology.

[26]  A. Lazenby,et al.  Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease , 2004, Hepatology.

[27]  H. Thomas,et al.  Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. , 2010, Journal of hepatology.

[28]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[29]  R O Morgan,et al.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.

[30]  B. Neuschwander‐Tetri,et al.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.

[31]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[32]  A. Dhawan,et al.  Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers , 2007, Hepatology.

[33]  G. Gores,et al.  Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.

[34]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[35]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[36]  Xiaoping Hu,et al.  Quantitative analysis of T2‐correction in single‐voxel magnetic resonance spectroscopy of hepatic lipid fraction , 2009, Journal of magnetic resonance imaging : JMRI.

[37]  Janardan K. Reddy,et al.  III. Peroxisomal β-oxidation, PPARα, and steatohepatitis , 2001 .

[38]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[39]  G. Perlemuter,et al.  Serum leptin in patients with alcoholic liver disease. , 2006, Alcoholism, clinical and experimental research.

[40]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[41]  V. Balasubramaniyan,et al.  Effect of leptin administration on membrane‐bound adenosine triphosphatase activity in ethanol‐induced experimental liver toxicity , 2006, The Journal of pharmacy and pharmacology.

[42]  J. Machan,et al.  Nonalcoholic Fatty Liver Disease in Severely Obese Subjects , 2007, The American Journal of Gastroenterology.

[43]  R. Goldin,et al.  Physiological hepatic nuclear vacuolation—how long does it persist? , 2010, Histopathology.

[44]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[45]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[46]  S. Sanderson,et al.  The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens. , 2005, American journal of clinical pathology.

[47]  G. Gores,et al.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .

[48]  E. Tsochatzis,et al.  The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases , 2006, The American Journal of Gastroenterology.

[49]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[50]  C. Tiribelli,et al.  Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells. , 1998, Gastroenterology.

[51]  J. Marrero,et al.  NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.

[52]  L. Nagy,et al.  Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[53]  Nash Crn.  Nonalcoholic steatohepatitis clinical research network , 2003, Hepatology.

[54]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[55]  I. Leclercq,et al.  Leptin is essential for the hepatic fibrogenic response to chronic liver injury. , 2002, Journal of hepatology.

[56]  D. Lobo,et al.  Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. , 2004, Journal of hepatology.

[57]  H. Nakamine,et al.  Clinical and pathological features of non-alcoholic steatohepatitis. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[58]  A. Feldstein,et al.  Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.

[59]  J B Saunders,et al.  Epidemiology of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.

[60]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[61]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[62]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[63]  E. Brunt.  Histopathology of non-alcoholic fatty liver disease. , 2009, Clinics in liver disease.

[64]  A. McCullough,et al.  Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology , 1998, American Journal of Gastroenterology.

[65]  P. Bejarano.  Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD—Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network , 2010 .

[66]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[67]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[68]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[69]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[70]  Udo Hoffmann,et al.  Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study , 2010, Hepatology.

[71]  S. Locarnini.  Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[72]  Zhang,et al.  Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanolinduced liver injury , 2006 .

[73]  J. Prieto,et al.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology , 2000, Gut.

[74]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[75]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[76]  G. Ansari,et al.  Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice. , 2006, Alcohol.

[77]  Y. Takei,et al.  Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. , 2002, Gastroenterology.

[78]  J. Everhart.  Alcohol and hepatitis C: do we have a drinking problem? , 2006, Gastroenterology.

[79]  A. Keshavarzian,et al.  Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. , 2009, Journal of hepatology.

[80]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[81]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[82]  C. Moskaluk,et al.  Hepatocellular ballooning in NASH. , 2010, Journal of hepatology.

[83]  K. Kawagoe,et al.  Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. , 1987, The American journal of gastroenterology.

[84]  J K Reddy,et al.  Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[85]  C. Day,et al.  Non-alcoholic steatohepatitis: another disease of affluence , 1999, The Lancet.

[86]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[87]  J. Takeda,et al.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. , 2007, World journal of gastroenterology.

[88]  A. Diehl.  Obesity and alcoholic liver disease. , 2004, Alcohol.

[89]  C. McClain,et al.  Mechanisms of non-alcoholic steatohepatitis. , 2004, Alcohol.

[90]  M. Ingelman-Sundberg,et al.  Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole , 1998, Hepatology.

[91]  V. Preedy,et al.  Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? , 2003, European journal of gastroenterology & hepatology.

[92]  Z. Younossi,et al.  Epidemiology and natural history of NAFLD and NASH. , 2007, Clinics in liver disease.

[93]  Kurt Zatloukal,et al.  p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. , 2002, The American journal of pathology.

[94]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[95]  Z. Gong,et al.  Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. , 2006, World journal of gastroenterology.

[96]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[97]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[98]  J. Ludwig,et al.  Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. , 2002, Journal of hepatology.

[99]  G. Gores,et al.  Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.

[100]  T. Liang,et al.  The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease , 2010, Hepatology.

[101]  S. French,et al.  CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. , 2006, Experimental and molecular pathology.

[102]  A. Cederbaum,et al.  Alcohol and oxidative liver injury , 2006, Hepatology.

[103]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[104]  R. Goldin,et al.  Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research , 2006, International journal of experimental pathology.

[105]  T. Ben-Menachem,et al.  Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients , 1999, American Journal of Gastroenterology.